HealthScience
Belgian Combo Therapy Halves Type 1 Diabetes Risk in Study
Belgian researchers from VUB and KU Leuven show a combination therapy targeting both immunity and beta cells halves type 1 diabetes risk in mice.
—4 min read
Tag
#Vub
3 articles
HealthScience
Belgian Researchers Unveil Dual Strategy for Type 1 Diabetes
VUB and KU Leuven researchers show combining immunotherapy with beta cell protection significantly slows type 1 diabetes in preclinical trials.
—4 min read
Science & Technology
Belgian Professor Steven Lowette Appointed to Top CERN Role
VUB Professor Steven Lowette becomes the first Belgian appointed as Physics Coordinator of the CMS experiment at CERN, overseeing major LHC research.
—5 min read